News
Check out the latest news, insights and unique analysis brought to you by Stockhead's team of business journalists and industry experts on Actinogen Medical.
RELATED STOCKHEAD STORIES
News
ASX Small Cap Lunch Wrap: Who’s on pace for their best week since November?
Health & Biotech
Clinical Trials Tracker: 2022 and beyond
News
Last Orders: What you might have missed on the ASX today
News
Closing Bell: Today’s biggest small caps movers on the ASX
Health & Biotech
Actinogen reveals its next clinical trial plans
News
10 at 10: These ASX stocks are galvanizing support this morning
News
Rise and Shine: What you need to know before the ASX opens
News
Rise and Shine: What you need to know before the ASX opens
Health & Biotech
Dr Boreham’s Crucible: Why Invex has all the right ingredients to possibly become a takeover target
Health & Biotech
Are we mortgaging the future as COVID-19 closes clinical trials?
Health & Biotech
Leaving out ladies could be costing biotechs a lot of money
News
Dementia sufferers in Australia will hit 1 million, can these small caps come up with a treatment?
Health & Biotech
Here’s how to pick a successful drug out of the 99pc of failures
Health & Biotech
Biotech: It’s not a get-rich-quick scheme judging by these HY reports
Health & Biotech
Brain health is complicated, but these ASX small caps are trying to keep it in shape
News
The 10 ASX stocks that more than tripled in a single day in 2019
Stockhead TV